At the conclusion of this activity, participants should be better able to:
Describe emerging oncology pharmacotherapy options and their mechanisms of action to support evidence-based treatment selection.
Evaluate patient- and drug-specific considerations for managing, monitoring, and adjusting oncology therapies to mitigate adverse effects and enhance therapeutic benefit.
Apply principles of precision medicine and molecular diagnostics to guide individualized cancer pharmacotherapy decision-making.
Develop strategies to improve adherence, optimize outcomes, and support transitions of care in oncology pharmacy practice.
Identify practice management innovations and operational efficiencies that enhance the value and sustainability of cancer care delivery.